Neoplasms Clinical Trial
Official title:
Effectiveness of an Integrated Experiential Training Program With Coaching by Nursing Students in Promoting Regular Physical Activity and Reducing Fatigue Among Childhood Cancer Patients
NCT number | NCT02754973 |
Other study ID # | UW15-219 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 2015 |
Est. completion date | November 2017 |
Verified date | June 2018 |
Source | The University of Hong Kong |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Despite the evidence that regular physical activity can have beneficial effects
on the physical and psychological well-being of cancer patients, a review of the literature
reveals that a majority of young cancer patients fail to attain the same levels of physical
activity that they had before contracting the disease. There is scientific evidence that
physical inactivity induces muscle catabolism and atrophy and cardiovascular diseases, which
may lead to a further increase in fatigue and a decrease in the functional capacity of cancer
patients. Empirical evidence is needed to explore an appropriate strategy for promoting
physical activity in such patients.
Purposes: To examine the effectiveness of an integrated experiential training program with
coaching by nursing students in promoting regular physical activity, reducing fatigue and
enhancing quality of life among Hong Kong Chinese childhood cancer patients.
Design and Subjects: A randomised controlled trial (RCT), two-group pre-test and repeated
post-test, within and between subjects design will be conducted. Recruitment of subjects will
be carried out in a paediatric oncology ward of a Hong Kong acute care hospital.
Intervention: Participants in the experimental group will join an integrated experiential
training program with coaching by nursing students, which contains 28 home visits by a
designated nursing student as a coach for a 6-month period. Those in the placebo control
group will receive an amount of time and attention (home visits by research assistants) that
mimics that received by the experimental group.
Status | Completed |
Enrollment | 70 |
Est. completion date | November 2017 |
Est. primary completion date | August 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 18 Years |
Eligibility |
Inclusion Criteria: - aged between 9 to 18 - diagnosed with cancer at some time in the previous month and currently undergoing active treatments - able to speak Cantonese and read Chinese Exclusion Criteria: - evidence of recurrence or second malignancies - physical impairment or cognitive or learning problems identified from their medical records |
Country | Name | City | State |
---|---|---|---|
China | The University of Hong Kong | Hong Kong |
Lead Sponsor | Collaborator |
---|---|
The University of Hong Kong |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in levels of cancer-related fatigue from baseline at 9 month follow-up between intervention and control group | The primary outcomes are levels of cancer-related fatigue at 9 months after starting the intervention. The Chinese version of Fatigue Scale will be used to assess the fatigue of subjects. | 9 month follow-up | |
Secondary | Levels of cancer-related fatigue at baseline | The Chinese version of Fatigue Scale will be used to assess the fatigue of subjects. | baseline | |
Secondary | Change in cancer-related fatigue from baseline at 6 month follow-up between intervention and control group | The Chinese version of Fatigue Scale will be used to assess the fatigue of subjects. | 6 month follow-up | |
Secondary | Levels of physical activity at baseline | The Chinese University of Hong Kong: Physical Activity Rating for Children and Youth (CUHK-PARCY) will be used to assess the physical activity levels of the participants. It contains only one item which was derived from the Jackson Activity Coding and the Godin-Shephard Activity Questionnaire Modified for Adolescents. Participants will be asked to respond to the Chinese version of the CUHK-PARCY before randomization. | baseline | |
Secondary | Levels of physical activity self-efficacy at baseline | The Physical Activity Self-Efficacy (PA-SE) will be used to measure the children's self-confidence in their ability to participate in various age-appropriate physical activities. The PA-SE includes five items in which children are asked if they are 'not sure', 'a little sure' or 'very sure' that they can do such things as 'keep up a steady pace without stopping for 15-20 min'. Higher scores indicate higher self-efficacy. Participants will be asked to respond to the Chinese version of the PA-SE before randomization. | baseline | |
Secondary | Change in levels of physical activity self-efficacy from baseline at 6 month follow-up | The Physical Activity Self-Efficacy (PA-SE) will be used to measure the children's self-confidence in their ability to participate in various age-appropriate physical activities. The PA-SE includes five items in which children are asked if they are 'not sure', 'a little sure' or 'very sure' that they can do such things as 'keep up a steady pace without stopping for 15-20 min'. Higher scores indicate higher self-efficacy. Participants will be asked to respond to the Chinese version of the PA-SE at 6 months after starting the intervention. | 6 month follow-up | |
Secondary | Change in levels of physical activity self-efficacy from baseline at 9 month follow-up | The Physical Activity Self-Efficacy (PA-SE) will be used to measure the children's self-confidence in their ability to participate in various age-appropriate physical activities. The PA-SE includes five items in which children are asked if they are 'not sure', 'a little sure' or 'very sure' that they can do such things as 'keep up a steady pace without stopping for 15-20 min'. Higher scores indicate higher self-efficacy. Participants will be asked to respond to the Chinese version of the PA-SE at 9 months after starting the intervention. | 9 month follow-up | |
Secondary | Depressive symptoms at baseline | The depressive symptoms will be measured by the Centre for Epidemiological Studies Depression Scale for Children (CES-DC). It consists of 20 items in which cancer patients rated their experience of the previous 7 days on a 4-point Likert scale (0 = 'not at all', 1 = 'a little', 2 = 'sometimes', 3 = 'a lot'). The scores range from 0 to 60 with 16 as the cut-off score to represent a significant level of depression in the children. Higher scores corresponds to more number of depressive symptoms. Participants will be asked to respond to the Chinese version of the CES-DC before randomization. | baseline | |
Secondary | Change in depressive symptoms from baseline at 6 month follow-up | The depressive symptoms will be measured by the Centre for Epidemiological Studies Depression Scale for Children (CES-DC). It consists of 20 items in which cancer patients rated their experience of the previous 7 days on a 4-point Likert scale (0 = 'not at all', 1 = 'a little', 2 = 'sometimes', 3 = 'a lot'). The scores range from 0 to 60 with 16 as the cut-off score to represent a significant level of depression in the children. Higher scores corresponds to more number of depressive symptoms. Participants will be asked to respond to the Chinese version of the CES-DC at 6 months after starting the intervention. | 6 month follow-up | |
Secondary | Change in depressive symptoms from baseline at 9 month follow-up | The depressive symptoms will be measured by the Centre for Epidemiological Studies Depression Scale for Children (CES-DC). It consists of 20 items in which cancer patients rated their experience of the previous 7 days on a 4-point Likert scale (0 = 'not at all', 1 = 'a little', 2 = 'sometimes', 3 = 'a lot'). The scores range from 0 to 60 with 16 as the cut-off score to represent a significant level of depression in the children. Higher scores corresponds to more number of depressive symptoms. Participants will be asked to respond to the Chinese version of the CES-DC at 9 months after starting the intervention. | 9 month follow-up | |
Secondary | Muscle strength at baseline | The right- and left-hand grip strengths of the participants were assessed by a dynamometer before randomization. | basline | |
Secondary | Change in muscle strength from baseline at 6 month follow-up between intervention and control group | The right- and left-hand grip strengths of the participants were assessed by a dynamometer 6 months after starting the intervention. | 6 month follow-up | |
Secondary | Change in muscle strength from baseline at 9 month follow-up between intervention and control group | The right- and left-hand grip strengths of the participants were assessed by a dynamometer 9 months after starting the intervention. | 9 month follow-up | |
Secondary | Levels of quality of life at baseline | The Quality of life of the participants will be measured by the Chinese version of the PedsQL cancer module v. 3.0. This scale consists of 27 items which are categorized into eight different subscales, namely pain and hurt (2 items), nausea (5 items), procedural anxiety (3 items), treatment anxiety (3 items), worry (3 items), cognitive problems (5 items), perceived physical appearance (3 items) and communication (3 items). All items are evaluated on 5-point Likert scale by which the participants will be asked how much of a problem has been experienced over the last month. Participants will be asked to respond to the Chinese version of the PedsQL cancer module v. 3.0 before randomization. | baseline | |
Secondary | Change in levels of quality of life from baseline at 6 month follow-up between intervention and control group | The Quality of life of the participants will be measured by the Chinese version of the PedsQL cancer module v. 3.0. This scale consists of 27 items which are categorized into eight different subscales, namely pain and hurt (2 items), nausea (5 items), procedural anxiety (3 items), treatment anxiety (3 items), worry (3 items), cognitive problems (5 items), perceived physical appearance (3 items) and communication (3 items). All items are evaluated on 5-point Likert scale by which the participants will be asked how much of a problem has been experienced over the last month. Participants will be asked to respond to the Chinese version of the PedsQL cancer module v. 3.0 at 6 months after starting the intervention. | 6 month follow-up | |
Secondary | Change in levels of quality of life from baseline at 9 month follow-up between intervention and control group | The Quality of life of the participants will be measured by the Chinese version of the PedsQL cancer module v. 3.0. This scale consists of 27 items which are categorized into eight different subscales, namely pain and hurt (2 items), nausea (5 items), procedural anxiety (3 items), treatment anxiety (3 items), worry (3 items), cognitive problems (5 items), perceived physical appearance (3 items) and communication (3 items). All items are evaluated on 5-point Likert scale by which the participants will be asked how much of a problem has been experienced over the last month. Participants will be asked to respond to the Chinese version of the PedsQL cancer module v. 3.0 at 9 months after starting the intervention. | 9 month follow-up | |
Secondary | Change in levels of physical activity from baseline at 9 month follow-up between intervention and control group | The Chinese University of Hong Kong: Physical Activity Rating for Children and Youth (CUHK-PARCY) will be used to assess the physical activity levels of the participants. It contains only one item which was derived from the Jackson Activity Coding and the Godin-Shephard Activity Questionnaire Modified for Adolescents. Participants will be asked to respond to the Chinese version of the CUHK-PARCY at 9 months after starting the intervention. | 9 month follow-up |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
Terminated |
NCT03166631 -
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
|
Phase 1 | |
Completed |
NCT01938846 -
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06058312 -
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
|
N/A | |
Completed |
NCT03308942 -
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
|
Phase 2 | |
Recruiting |
NCT06018311 -
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads
|
N/A | |
Withdrawn |
NCT05431439 -
Omics of Cancer: OncoGenomics
|
||
Completed |
NCT01343043 -
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
|
Phase 1 | |
Completed |
NCT01938638 -
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
|
Phase 1 | |
Recruiting |
NCT05514444 -
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)
|
Phase 1 | |
Recruiting |
NCT02292641 -
Beyond TME Origins
|
N/A | |
Terminated |
NCT00954512 -
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04958239 -
A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
|
Phase 1 | |
Recruiting |
NCT04627376 -
Multimodal Program for Cancer Related Cachexia Prevention
|
N/A | |
Completed |
NCT01222728 -
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
|
||
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Active, not recruiting |
NCT05636696 -
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
|
N/A | |
Not yet recruiting |
NCT06035549 -
Resilience in East Asian Immigrants for Advance Care Planning Discussions
|
N/A | |
Recruiting |
NCT06004466 -
Noninvasive Internal Jugular Venous Oximetry
|
||
Completed |
NCT03190811 -
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors
|
Phase 1/Phase 2 |